[HTML][HTML] Stem cell-and cell-based therapies for ischemic stroke
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - Bioengineering, 2022 - mdpi.com
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
[HTML][HTML] Stem Cell-and Cell-Based Therapies for Ischemic Stroke
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - …, 2022 - ncbi.nlm.nih.gov
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
Stem Cell-and Cell-Based Therapies for Ischemic Stroke
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - …, 2022 - search.proquest.com
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
Stem Cell-and Cell-Based Therapies for Ischemic Stroke
DC Nistor-Cseppentö, MC Jurcău… - Bioengineering …, 2022 - pubmed.ncbi.nlm.nih.gov
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
Stem Cell-and Cell-Based Therapies for Ischemic Stroke.
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - Bioengineering …, 2022 - europepmc.org
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
Stem Cell-and Cell-Based Therapies for Ischemic Stroke
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - 2022 - agris.fao.org
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
Stem Cell-and Cell-Based Therapies for Ischemic Stroke.
DC Nistor-Cseppentö, MC Jurcău, A Jurcău… - Bioengineering …, 2022 - europepmc.org
Stroke is the second cause of disability worldwide as it is expected to increase its incidence
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …
and prevalence. Despite efforts to increase the number of patients eligible for recanalization …